SEC Form D · filed September 14, 2015
Strongbridge Biopharma plc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (24)
Garheng H. Kong · Trevose, PADirectorStephen B. Long · Trevose, PAExecRobert B. Lutz · Trevose, PAExecRichard H. Kollender · Trevose, PADirectorRuth Thieroff-Ekerdt · Trevose, PAExecMatthew Pauls · Trevose, PAExec · DirectorMarten H. Steen · Trevose, PADirectorJohn H. Johnson · Trevose, PADirectorHilde H. Steineger · Trevose, PADirectorA. Brian Davis · Trevose, PAExecJerome Ternynck · San Francisco, CAExecSteven E. Hubbard · McMinnville, TNExecRobbie Vann-Adibe · San Francisco, CADirectorDavid Chancogne · San Francisco, CADirectorSmith Donn · Grand Rapids, MIExec · DirectorDermot Butler · Dublin 2, IrelandExec · DirectorJohn Skelly · Dublin 2, IrelandDirectorAlan Tooker · Dublin 2, IrelandExec · DirectorMarie-Caroline Stievenart · Dublin 2, IrelandExec · DirectorRoss H. Martinson · New York, NYDirectorJohn H. Watts · New York, NYDirectorTorrance Robinson · New York, NYDirectorJohn Aiello · New York, NYExec · DirectorA. Brian Davis · Trevose, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗